Four Fresh New Perspectives on Telemedicine for Health Execs

Healthcare executives are interested in telemedicine. In fact, for the majority, it is high on their radar, according to a new survey. According to Defining Telemedicine’s Role: The View From the C-Suite, from Sage Growth Partners (SGP), a Baltimore-based healthcare research, strategy, and marketing firm, 86% of healthcare executives say telemedicine is […]


What to Know About Working with PBMs

A Pharmacy Benefit Manager (PBM) is a third party administrator contracted by health plans, employers, unions and government entities to manage prescription drug programs. A PBM acts as a fiscal intermediary between insurers/payors and pharmacies. There is an old saying, ‘Possession is 9/10ths of the law,’ and that applies to PBMs. […]


Minister Bruno Bruins investeert 10 miljoen extra per jaar in topsport

Nieuwsbericht | 20-02-2018 | 17:29 Meer topcoaches van Nederlandse bodem, extra deelname aan internationale wedstrijden en trainingsstages voor topsporters, betere herkenning en ontwikkeling van toptalenten en meer geld voor financiële voorzieningen voor talenten en topsporters. Dat is een greep uit de doelen die minister Bruno Bruins (Sport) de komende jaren […]


Dynavax secures $175M to fuel Heplisav-B marketing, immuno-oncology trials

About a month after launching Heplisav-B in the U.S., Dynavax is putting big money behind the hepatitis B vaccine. In an agreement with investment firm CRG LP, Dynavax could receive up to $175 million in a loan to support the vaccine’s commercialization. The loan is divided into two parts, with $100 […]


Powerful Antibiotics Found in Dirt

Caption: Researchers found a new class of antibiotics in a collection of about 2,000 soil samples.Credit: Sean Brady, The Rockefeller University, New York Many of us think of soil as lifeless dirt. But, in fact, soil is teeming with a rich array of life: microbial life. And some of those […]


Le service sanitaire

Porté conjointement par le ministère des Solidarités et de la Santé et le ministère, de l’Enseignement Supérieur, de la Recherche et de l’Innovation, le service sanitaire s’adresse à tous les étudiants en santé avec pour but de les familiariser avec les enjeux de prévention en santé. Le Service sanitaire prendra […]


Programme

A partir de 9h30 Accueil des participants 10h00 Ouverture du séminaire par Cécile Courrèges, directrice générale de l’offre de soins 10h15 Intervention : SSR : état des lieux (DGOS) 10h35 Intervention : SSR : cartographie régionale de l’offre et retour d’expériences (ANAP) Echange avec la salle 11h30 Table ronde : […]


N° 49 – PHMEV en 2016

Les prescriptions hospitalières de médicaments délivrés en ville en 2016 et les évolutions depuis 2004. Points de repère n° 49, février 2018 La place des prescriptions hospitalières exécutées en ville (PHEV) est de plus en plus importante. En 2016, avec 11,7 milliards d’euros remboursés par le régime général de l’Assurance […]


Guide “Les enfants pupilles de l’État”

Le présent guide explicite le droit applicable à la tutelle spécifique des pupilles de l’État et fournit en annexes des modèles de documents. Il s’adresse aux directions départementales de la cohésion sociale, tuteurs des enfants pupilles de l’État par représentation du préfet, et aux conseils départementaux, services gardien de ces […]


NICE recommends thyroid cancer drug trio for NHS use

NICE has announced its decision to recommend that three separate treatments for thyroid cancer should be made available for use of the NHS: Ipsen’s Cometriq (cabozantinib), Bayer’s Nexavar (sorafenib), and Eisai’s Lenvima (lenvatinib). The former two were previously only available via the Cancer Drugs Fund (CDF), and the latter sees […]


Shire, Microsoft and EURORDIS form rare disease alliance

Rare disease specialist pharma firm Shire, rare disease patient alliance EURORDIS and tech giant Microsoft have announced they have formed a partnership focused on addressing diagnostic challenges with rare diseases, aiming to provide support and shorten the time it takes for patients and their families to reach a conclusive diagnosis. […]


Japan's Oncolys invests £3m in adenovirus firm Unleash Immuno Oncolytics

Unleash Immuno Oncolytics, a US firm focusing on the development of viral biologics in the treatment of cancer, has attracted the attention of publicly-traded Japanese firm Oncolys BioPharma, which has decided to invest $3 million in the St Louis-based start-up. Both Unleash and Oncolys are in the development of oncolytic […]


Fra i dag sendes alle breve om markedsføringstilladelser digitalt til danske virksomheder

20. februar 2018 Fra i dag udvider Lægemiddelstyrelsen brugen af digital post og sender alle breve, og ikke kun afgørelser, om markedsføringstilladelser digitalt til danske virksomheder. Det gælder for alle breve vedrørende både nye markedsføringstilladelser, variationer og forlængelser samt eventuelle bilag – og for både humane og veterinære lægemidler. Den […]


Lilly dumps Hanmi’s rheumatoid arthritis med

Eli Lilly and Hanmi signed an exclusive licensing and collaboration agreement to develop the Bruton’s tyrosine kinase (BTK) inhibitor, HM71224, for the treatment of various autoimmune and other diseases in 2015. The deal was worth a potential $690 million in total but that hasn’t stopped Lilly showing every sign of […]